We hypothesize that ↑MCT1 expression in NSCLC cancer cells serve as a positive prognostic factor, because its expression indicates an overall less aggressive oxidative/metabolic cancer phenotype in NSCLC. The gene discussed is SLC16A1; the disease is metabolic process.